Abstract:Alzheimer’s disease(AD) is characterized by early neuropathological pathways-extracellular fibrillar β-amyloid(Aβ) deposits in the brain,intracellular neurofibrillary tangles(NFTs),possibly leading to synaptic dysfunction,neurodegeneration and cognitive/functional decline.The clinical diagnosis of probable AD based on standard diagnostic criteria does not take into account the long preclinical and prodromal course of AD.Diagnosis was based on structured history,neurological examination and neuropsychological assessment,with emphasis on qualitative as well as quantitative aspects of performance.AD-related pathophysiological changes can occur many years and even decades before the appearance of clinical dementia syndrome.Biomarkers that are related to the pathophysiology of AD may thus be helpful in detecting the preclinical stages of disease,and improve early and differential diagnosis,provided that the biomarkers were specific enough to avoid interfering with normal processes and accuracy of preclinical diagnosis of AD was increasingly important for therapeutic and prognostic investigations.

Relationship of Pathogeneses with Diagnostic and Therapeutic Approaches to Alzheimer’s Disease